Hospital-Acquired Disease Testing Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Hospital-Acquired Disease Testing Market to 2027 - Global Analysis and Forecasts By Test Type (UTI Tests, SSI Tests, Pneumococcal Infection Tests, Bloodstream Infection Tests, and MRSA Tests) End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Community Health Centers) and Geography

Report Code: TIPBT00002662 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Hospital acquired infections are caused due to viral, fungal and bacterial pathogens. A nosocomial infection also referred to as hospital-acquired infections occurs because of an infectious agent or toxin that exists in certain location of a medical facility. One of the most common wards where HAIs occur is the intensive care unit (ICU), where doctors treat serious diseases. Hospital-acquired diseases continue to be a major concern for healthcare industry.

The market for hospital-acquired disease testing market is expected to witness growth due to increasing number of patients suffering with hospital-acquired infections. Moreover, advancing healthcare infrastructures with introduction of infection surveillance solutions and systems suggesting risks and action plans to manage these diseases are further expected to drive the growth of the market. However, inadequate security in healthcare facilities and lack of funding in developing and under-developed economies are likely to hinder hospital-acquired disease testing market growth.

The "Global Hospital-Acquired Disease Testing Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global hospital-acquired disease testing market with detailed market segmentation by test type and end user. The global hospital-acquired disease testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The global hospital-acquired disease testing market is segmented on the basis of test type and end user. On the basis of test type, the global hospital-acquired disease testing market is segmented into UTI tests, SSI tests, pneumococcal infection tests, bloodstream infection tests, and MRSA tests. Based on end user, the hospital-acquired disease testing market is segmented into hospitals, clinics, ambulatory surgical centers, and community health centers.

The hospital-acquired disease testing market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global hospital-acquired disease testing market based test type and end user. It also provides market size and forecast till 2027 for overall hospital-acquired disease testing market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America dominated the hospital-acquired disease testing market in 2017, owing rising awareness among the patient population as well as developing healthcare infrastructure. Asia Pacific on the other hand is expected witness the highest growth over the forecast period in the hospital-acquired disease testing market owing to the availability of immense opportunities in countries like India, China & Japan. Sanitation problems in the healthcare facilities and increasing number of hospitals admissions are expected to be the driving factors for Asian growth.

The hospital-acquired disease testing market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The hospital-acquired disease testing market report also includes the profiles of key hospital-acquired disease testing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Thermo Fisher Scientific Inc., Diatherix Eurofins, LLC, QIAGEN, Meridian Bioscience, Inc., Nordion (Canada) Inc., F. Hoffmann La Roche Ltd, Cantel Medical, Cepheid, Clinical Lab Products, and McKesson Medical-Surgical Inc. among others.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. HOSPITAL-ACQUIRED DISEASE TESTING MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Hospital-Acquired Disease Testing Market - By Test Type
3.2.2. Hospital-Acquired Disease Testing Market - By End User
3.2.3. Hospital-Acquired Disease Testing Market - By Region
3.2.3.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis

4. HOSPITAL-ACQUIRED DISEASE TESTING MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS

5. HOSPITAL-ACQUIRED DISEASE TESTING MARKET - GLOBAL ANALYSIS
5.1. GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET OVERVIEW
5.2. GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS

6. HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS TO 2027 - BY TEST TYPE
6.1. OVERVIEW
6.2. TEST TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. URINARY TRACT INFECTION (UTI) TESTS MARKET
6.3.1. Overview
6.3.2. Urinary Tract Infection (UTI) Tests Market Revenue Forecasts and Analysis (US$ Mn)
6.4. SURGICAL SITE INFECTION (SSI) TESTS MARKET
6.4.1. Overview
6.4.2. Surgical Site Infection (SSI) Tests Market Revenue Forecasts and Analysis (US$ Mn)
6.5. PNEUMOCOCCAL INFECTION TESTS MARKET
6.5.1. Overview
6.5.2. Pneumococcal Infection Tests Market Revenue Forecasts and Analysis (US$ Mn)
6.6. BLOODSTREAM INFECTION TESTS MARKET
6.6.1. Overview
6.6.2. Bloodstream Infection Tests Market Revenue Forecasts and Analysis (US$ Mn)
6.7. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) TESTS MARKET
6.7.1. Overview
6.7.2. methicillin-Resistant Staphylococcus aureus (MRSA) Tests Market Revenue Forecasts and Analysis (US$ Mn)


7. HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
7.1. OVERVIEW
7.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. HOSPITALS MARKET
7.3.1. Overview
7.3.2. Hospitals Market Revenue Forecasts and Analysis (US$ Mn)
7.4. CLINICS MARKET
7.4.1. Overview
7.4.2. Clinics Market Revenue Forecasts and Analysis (US$ Mn)
7.5. AMBULATORY SURGICAL CENTERS MARKET
7.5.1. Overview
7.5.2. Ambulatory Surgical Centers Market Revenue Forecasts and Analysis (US$ Mn)
7.6. COMMUNITY HEALTH CENTERS MARKET
7.6.1. Overview
7.6.2. Community Health Centers Market Revenue Forecasts and Analysis (US$ Mn)

8. NORTH AMERICA HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
8.1. NORTH AMERICA HOSPITAL-ACQUIRED DISEASE TESTING MARKET OVERVIEW
8.2. NORTH AMERICA HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
8.3. NORTH AMERICA HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY TEST TYPE (US$ MN)
8.4. NORTH AMERICA HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
8.5. NORTH AMERICA HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
8.6. US MARKET OVERVIEW
8.6.1. US Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By Test Type (US$ Mn)
8.6.2. US Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By End User (US$ Mn)
8.7. CANADA MARKET OVERVIEW
8.7.1. Canada Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By Test Type (US $ Mn)
8.7.2. Canada Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By End User (US $ Mn)
8.8. MEXICO MARKET OVERVIEW
8.8.1. Mexico Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By Test Type (US $ Mn)
8.8.2. Mexico Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By End User (US $ Mn)

9. EUROPE HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. EUROPE HOSPITAL-ACQUIRED DISEASE TESTING MARKET OVERVIEW
9.2. EUROPE HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. EUROPE HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY TEST TYPE (US$ MN)
9.4. EUROPE HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.5. EUROPE HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.6. FRANCE MARKET OVERVIEW
9.6.1. France Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By Test Type (US $ Mn)
9.6.2. France Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By End User (US $ Mn)
9.7. GERMANY MARKET OVERVIEW
9.7.1. Germany Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By Test Type (US $ Mn)
9.7.2. Germany Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By End User (US $ Mn)
9.8. UK MARKET OVERVIEW
9.8.1. UK Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By Test Type (US $ Mn)
9.8.2. UK Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By End User (US $ Mn)

10. ASIA PACIFIC HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. ASIA PACIFIC HOSPITAL-ACQUIRED DISEASE TESTING MARKET OVERVIEW
10.2. ASIA PACIFIC HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. ASIA PACIFIC HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY TEST TYPE (US$ MN)
10.4. ASIA PACIFIC HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.5. ASIA PACIFIC HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.6. CHINA MARKET OVERVIEW
10.6.1. China Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By Test Type (US $ Mn)
10.6.2. China Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By End User (US $ Mn)
10.7. INDIA MARKET OVERVIEW
10.7.1. India Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By Test Type (US $ Mn)
10.7.2. India Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By End User (US $ Mn)
10.8. JAPAN MARKET OVERVIEW
10.8.1. Japan Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By Test Type (US $ Mn)
10.8.2. Japan Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By End User (US $ Mn)

11. MIDDLE EAST AND AFRICA (MEA) HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. MIDDLE EAST AND AFRICA (MEA) HOSPITAL-ACQUIRED DISEASE TESTING MARKET OVERVIEW
11.2. MIDDLE EAST AND AFRICA (MEA) HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. MIDDLE EAST AND AFRICA (MEA) HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY TEST TYPE (US$ MN)
11.4. MIDDLE EAST AND AFRICA (MEA) HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.5. MIDDLE EAST AND AFRICA (MEA) HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.6. SOUTH AFRICA MARKET OVERVIEW
11.6.1. South Africa Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By Test Type (US $ Mn)
11.6.2. South Africa Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By End User (US $ Mn)
11.7. SAUDI ARABIA MARKET OVERVIEW
11.7.1. Saudi Arabia Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By Test Type (US $ Mn)
11.7.2. Saudi Arabia Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By End User (US $ Mn)
11.8. UAE MARKET OVERVIEW
11.8.1. UAE Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By Test Type (US $ Mn)
11.8.2. UAE Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By End User (US $ Mn)

12. SOUTH AND CENTRAL AMERICA HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. SOUTH AND CENTRAL AMERICA HOSPITAL-ACQUIRED DISEASE TESTING MARKET OVERVIEW
12.2. SOUTH AND CENTRAL AMERICA HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. SOUTH AND CENTRAL AMERICA HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY TEST TYPE (US$ MN)
12.4. SOUTH AND CENTRAL AMERICA HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.5. SOUTH AND CENTRAL AMERICA HOSPITAL-ACQUIRED DISEASE TESTING MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.6. BRAZIL MARKET OVERVIEW
12.6.1. Brazil Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By Test Type (US $ Mn)
12.6.2. Brazil Hospital-Acquired Disease Testing Market Revenue and Forecasts Analysis - By End User (US $ Mn)

13. INDUSTRY LANDSCAPE
13.1. ORGANIC GROWTH STRATEGIES
13.1.1. New Product Launches
13.1.2. Marketing & Promotional Activities
13.2. INORGANIC GROWTH STRATEGIES
13.2.1. Partnerships, Collaborations, and Joint Ventures
13.2.2. Mergers & Acquisitions

14. HOSPITAL-ACQUIRED DISEASE TESTING MARKET, KEY COMPANY PROFILES
14.1. THERMO FISHER SCIENTIFIC INC.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. DIATHERIX EUROFINS, LLC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. QIAGEN
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Financial Overview
14.3.4. Product Portfolio
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. MERIDIAN BIOSCIENCE, INC.
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. NORDION (CANADA) INC.
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. F. HOFFMANN LA ROCHE LTD
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. CANTEL MEDICAL
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. CEPHEID
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Financial Overview
14.8.4. Product Portfolio
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. CLINICAL LAB PRODUCTS
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Financial Overview
14.9.4. Product Portfolio
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. MCKESSON MEDICAL-SURGICAL INC.
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Financial Overview
14.10.4. Product Portfolio
14.10.5. SWOT Analysis
14.10.6. Key Developments

15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
15.3. RESEARCH METHODOLOGY
The List of Companies

1. THERMO FISHER SCIENTIFIC INC.
2. DIATHERIX EUROFINS, LLC
3. QIAGEN
4. MERIDIAN BIOSCIENCE, INC.
5. NORDION (CANADA) INC.
6. F. HOFFMANN LA ROCHE LTD
7. CANTEL MEDICAL
8. CEPHEID
9. CLINICAL LAB PRODUCTS
10. MCKESSON MEDICAL-SURGICAL INC.
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book